Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)
Clinical trial NCT04278885 · UNKNOWN
Trial details
- NCT number
- NCT04278885
- Sponsor
- Charite University, Berlin, Germany
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2024-12-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.